发明名称 |
Crystal form of dabrafenib and preparation method and use thereof |
摘要 |
The invention relates to Crystal Form VII of dabrafenib and preparation method thereof, wherein Crystal Form VII has the advantage of being more stable at room temperature or in aqueous systems, and has low hygroscopicity, and thus is more suitable for a wet granulation process or being prepared into a suspension; and the present invention also relates to a pharmaceutical composition and formulations comprising Crystal Form VII, and their use in the treatment of Raf family kinase-related diseases. |
申请公布号 |
US9458149(B2) |
申请公布日期 |
2016.10.04 |
申请号 |
US201615081498 |
申请日期 |
2016.03.25 |
申请人 |
HANGZHOU PUSHAI PHARMACEUTICAL TECHNOLOGY CO., LTD. |
发明人 |
Lao Haiping;Sheng Xiaoxia;Sheng Xiaohong |
分类号 |
C07D417/04;C30B7/06;C30B7/14;C30B29/54 |
主分类号 |
C07D417/04 |
代理机构 |
Sterne, Kessler, Goldstein & Fox PLLC |
代理人 |
Sterne, Kessler, Goldstein & Fox PLLC |
主权项 |
1. Crystal Form VII of Dabrafenib with the structural formula shown below,characterized by a X-ray powder diffraction pattern measured using Cu-Kα radiation having the specific peaks at the diffraction angle 2θ of 7.9±0.2°, 14.5±0.2°, 19.4±0.2° and 24.3±0.2°. |
地址 |
Hangzhou CN |